{"nctId":"NCT00765882","briefTitle":"Phase III, Randomized, Double-Blind, Placebo-Controlled, Trial of Linaclotide Administered to Patients With Chronic Constipation","startDateStruct":{"date":"2008-09"},"conditions":["Chronic Constipation"],"count":633,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: Linaclotide 290 micrograms"]},{"label":"2","type":"EXPERIMENTAL","interventionNames":["Drug: Linaclotide 145 micrograms"]},{"label":"3","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Linaclotide 290 micrograms","otherNames":[]},{"name":"Linaclotide 145 micrograms","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patient has completed a colonoscopy according to the AGA criteria, with no clinically significant findings\n* Patient has successfully completed protocol procedures (with no clinically significant findings): physical exam, 12-lead ECG, or clinical laboratory tests\n* Patient meets protocol criteria for CC: reports \\< 3 bowel movements per week and reports straining, lumpy or hard stools, and/or sensation of incomplete evacuation during \\> 25% of BMs\n* Patient demonstrates continued chronic constipation through Pretreatment Period\n* Patient is compliant with IVRS\n\nExclusion Criteria:\n\n* Patient has history of loose or watery stools\n* Patient has symptoms of or been diagnosed with Irritable Bowel Syndrome (IBS)\n* Patient has a structural abnormality of the gastrointestinal (GI) tract or a disease or condition that can affect GI motility\n* Patient has any protocol-excluded or clinically significant medical or surgical history that could confound the study assessments","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Complete Spontaneous Bowel Movement (CSBM) Overall Responder","description":"A 12-week CSBM overall responders was defined as a patient who for at least 9 of the 12 weeks of the treatment period had a CSBM weekly frequency rate that was 3 or greater and increased by 1 or more from baseline.\n\nA CSBM was defined as a spontaneous bowel movement (SBM) that was associated with a sense of complete evacuation.\n\nAn SBM was defined as a bowel movement (BM) that occurred in the absence of laxative, enema, or suppository use on either the calendar day of the BM or the calendar day before the BM.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13","spread":null},{"groupId":"OG001","value":"34","spread":null},{"groupId":"OG002","value":"43","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"202","spread":null},{"groupId":"OG001","value":"179","spread":null},{"groupId":"OG002","value":"159","spread":null}]}]}]},{"type":"SECONDARY","title":"12-week Complete Spontaneous Bowel Movement (CSBM) Frequency Rate","description":"The number of CSBMs per week.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.614","spread":"0.209"},{"groupId":"OG001","value":"2.011","spread":"0.215"},{"groupId":"OG002","value":"2.653","spread":"0.217"}]}]}]},{"type":"SECONDARY","title":"12-Week Spontaneous Bowel Movement (SBM) Frequency Rate","description":"A patient's 12-week spontaneous bowel movement (SBM) frequency rate was the number of SBMs per week calculated over the 12-weeks of the treatment period.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.113","spread":"0.265"},{"groupId":"OG001","value":"3.466","spread":"0.272"},{"groupId":"OG002","value":"3.675","spread":"0.275"}]}]}]},{"type":"SECONDARY","title":"12-Week Stool Consistency","description":"The consistency of each BM was assessed using the 7-point Bristol Stool Form Scale:\n\n1. = separate hard lumps like nuts \\[difficult to pass\\]\n2. = sausage shaped but lumpy\n3. = like a sausage but with cracks on surface\n4. = like a sausage or snake, smooth and soft\n5. = soft blobs with clear-cut edges \\[passed easily\\]\n6. = fluffy pieces with ragged edges, a mushy stool\n7. = watery, no solid pieces \\[entirely liquid\\]","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.572","spread":"0.098"},{"groupId":"OG001","value":"1.823","spread":"0.100"},{"groupId":"OG002","value":"2.009","spread":"0.103"}]}]}]},{"type":"SECONDARY","title":"12-Week Severity of Straining","description":"Straining is measured on a 5-point scale, where a value of 1 is \"not at all\" and a value of 5 is \"an extreme amount.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.554","spread":"0.060"},{"groupId":"OG001","value":"-1.141","spread":"0.061"},{"groupId":"OG002","value":"-1.208","spread":"0.063"}]}]}]},{"type":"SECONDARY","title":"12-Week Abdominal Discomfort","description":"Abdominal discomfort is based on a 5-point scale where a value of l is \"none\" and a value of 5 is \"very severe.\"","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.271","spread":"0.043"},{"groupId":"OG001","value":"-0.455","spread":"0.044"},{"groupId":"OG002","value":"-0.485","spread":"0.045"}]}]}]},{"type":"SECONDARY","title":"12-Week Bloating","description":"Bloating was based on a 5-point scale where a value of l is \"none\" and a value of 5 is \"very severe\".","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.244","spread":"0.048"},{"groupId":"OG001","value":"-0.432","spread":"0.049"},{"groupId":"OG002","value":"-0.485","spread":"0.049"}]}]}]},{"type":"SECONDARY","title":"12-Week Constipation Severity","description":"Constipation severity was based on a 5-point ordinal scale where a value of l is \"none\" and a value of 5 is \"very severe\".","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.306","spread":"0.062"},{"groupId":"OG001","value":"-0.908","spread":"0.063"},{"groupId":"OG002","value":"-0.954","spread":"0.064"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":215},"commonTop":["Diarrhea","Flatulence","Upper respiratory tract infection","Abdominal pain"]}}}